Probing the flexibility of G0
- Institution
- UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI
- Principal investigator
- Laura A Buttitta
- Funding
- $344K
- Duration
- 2023–2028
Moonbase score
Still being scored
Abstract
Project Summary/Abstract The cell cycle is an ordered series of molecular events in a cell leading to division and production of two daughter cells. This process is fundamental to the development of all multicellular organisms, which begin from a single cell, the fertilized egg. Equally important for proper development though, is the slowing or stopping of the cell cycle at the right places and times as cells, tissues and organs mature. In fact, the majority of cells in multicellular organisms spend most of their existence in non-proliferating states, often referred to as cellular quiescence or the G0 phase. In their non-dividing state, quiescent cells are metabolically active and carry out critical physiological functions in tissues and organs. Despite the importance of G0, most studies of cell cycle regulation have focused on rapidly dividing cells. Thus, it remains unclear how cells choose to enter G0 during development, and why some cells can choose to leave G0 and later re-enter the cell cycle in response to developmental signals, tissue damage, or nutrient availability while others cannot. It has become clear that there are multiple states of G0, some that are readily reversible, and others that are permanent. Different states of states may be controlled in distinct ways, both in the manner of cell cycle inhibition and in the pathways used to initiate exit. The goal of the work described here is to understand how the cell cycle machinery is controlled during the decision to exit the cell cycle, and how G0 can be modulated to be more or less reversible in different contexts. This work impacts a wide range of biological questions, as the proper control of quiescence is critical in development and tissue regeneration, but becomes disrupted in aging and cancer.
LOADING MOONBASE SCORE
Questions for UNIVERSITY OF MICHIGAN AT ANN ARBOR
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NIH · University of Michigan at Ann Arbor70
Biomarkers in the Hyperbaric Oxygen in Brain Injury Treatment Trial
Frederick Kofi Korley · $559K · 2020–2027
- NIH · University of Michigan at Ann Arbor64
Identification of Mild Cognitive Impairment using Machine Learning from Language and Behavior Markers
Hiroko Hayama Dodge · $733K · 2021–2027
- NIH · University of Michigan at Ann Arbor63
Role of Adaptive Myelination in Auditory Brain Plasticity
Jun Hee Kim · $511K · 2021–2027